Clinical Study
Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma
Figure 2
L-EGFR (a) and H-Beclin1 (b) patterns of protein expression in a GB. The arrows indicate the endothelium of vessels, negative for EGFR (a) and positive for Beclin1 (b) Immunohistochemistry, diaminobenzidine, original magnification ×200. (c) MRI T1-sequence with gadolinium shows a left temporal glioblastoma (white arrow) before treatment. (d) Radiological complete response (white arrow) after treatment (MRI at 4 months after adjuvant RT-CHT treatment).
(a) |
(b) |
(c) |
(d) |